Now I have enough comprehensive information from authoritative textbooks. Let me compile the complete 20-mark university exam answer.
Near Total Laryngectomy (NTL)
MS ENT University Exam - 20 Marks Answer
INTRODUCTION / DEFINITION
Near total laryngectomy (NTL) is a surgical procedure described by Pearson (1980) in which the entire larynx is removed except for a small remnant consisting of one arytenoid, a strip of the contralateral vocal cord mucosa, and a portion of the cricoid cartilage. This remnant is fashioned into a biological (innervated) voice shunt that connects the trachea to the pharynx, enabling lung-powered speech while the patient breathes through a permanent tracheostome.
It occupies a position midway between voice-conserving laryngectomy and total laryngectomy - it sacrifices nasal respiration but preserves voice.
- Cummings Otolaryngology Head and Neck Surgery
- Scott-Brown's Otorhinolaryngology Head & Neck Surgery
HISTORICAL NOTE
- First described by Pearson and colleagues (Mayo Clinic)
- Also referred to in older literature as "subtotal laryngectomy"
- Abbreviation: NTL (or NTLP = near-total laryngectomy with partial pharyngectomy)
CONCEPT AND PRINCIPLE
The NTL is not an organ-sparing operation but rather a technique for creating a natural voice shunt - an alternative to tracheoesophageal puncture (TEP) with a prosthesis.
The voice shunt mechanism:
- A small laryngotracheal remnant (one arytenoid + cricoid strip + overlying mucosa) is preserved on the less-involved / contralateral side
- This remnant is tubularized into a conduit between the trachea and the neopharynx
- The shunt is innervated and has sphincteric (dynamic) action - protecting the airway and preventing aspiration
- On occluding the tracheostome, exhaled air is diverted through the shunt into the pharynx, producing voice
- The shunt is too narrow to serve as an airway for breathing (hence the permanent tracheostome) but sufficient for voice production
"Some surgeons have advocated the near-total laryngectomy, which is not an organ-sparing operation but rather a technique for creating a natural voice shunt." - Cummings Otolaryngology
INDICATIONS
Primary indication:
- Advanced laryngeal and hypopharyngeal cancers (T3/T4) that are unsuitable for other conservation procedures but where a small laryngeal remnant can still be safely preserved
Specific indications:
- Glottic carcinoma - T3/T4 tumors with vocal cord fixation, unsuitable for supracricoid partial laryngectomy
- Hypopharyngeal cancers (especially pyriform sinus) - advanced but lateralized lesions where the contralateral arytenoid and cord are free of tumor
- Transglottic carcinomas where one side is relatively free
- Cases where the surgeon wishes to avoid a TEP prosthesis (as a natural shunt alternative)
NTL may be suitable in approximately 20% of advanced operable pyriform sinus cancers (the most common hypopharyngeal site).
CONTRAINDICATIONS
| Contraindication | Reason |
|---|
| Interarytenoid or post-cricoid mucosal involvement | Makes preservation of the contralateral arytenoid oncologically unsafe |
| Mucosal involvement of >1/3 the length of the contralateral cord | Insufficient remnant for shunt formation |
| Bilateral arytenoid/cord involvement | No remnant to preserve |
| Prior radiation therapy (relative) | Oedematous, compromised tissue - higher fistula risk; shunt healing is poor |
| Fixed lymph nodes / distant metastasis | Palliative intent - NTL not indicated |
SURGICAL TECHNIQUE
Preoperative preparation:
- Imaging: CT/MRI to assess extent of tumor
- Biopsy confirmation
- Neck dissection planned (unilateral or bilateral depending on nodal status)
- Counseling regarding permanent tracheostome
Steps of the procedure:
-
Position and incision: Apron flap incision; subplatysmal flaps raised
-
Neck dissection: Functional or modified radical neck dissection on the involved side; contralateral neck dissected as indicated by nodal status
-
Laryngeal exposure: Strap muscles divided; thyroid gland managed (ipsilateral thyroid lobe may be resected)
-
Assessment of the contralateral side: The contralateral arytenoid, posterior cricoarytenoid (PCA) muscle, and recurrent laryngeal nerve are carefully assessed for tumor-free status
-
Resection: The entire larynx is removed except for:
- The contralateral arytenoid cartilage
- A cuff of mucosa from the contralateral vocal cord/subglottis
- A portion of the posterior cricoid cartilage on the preserved side
-
Shunt construction: The preserved remnant (arytenoid + mucosa + cricoid strip) is fashioned into a tubular conduit (myomucosal tube) connecting the superior end of the trachea to the neopharynx
-
Pharyngeal closure: The neopharynx is closed primarily around the shunt
-
Tracheostome: A permanent tracheostome is fashioned at the lower neck
-
Wound closure and drain placement
POSTOPERATIVE MANAGEMENT
- Feeding: Nasogastric tube for 7-10 days (until pharyngeal healing)
- Tracheostome care: Humidification, cleaning, suction
- Voice rehabilitation: Patient learns to occlude the tracheostome with a finger and exhale - air travels through the shunt producing voice (no prosthesis required)
- Swallowing: The sphincteric shunt protects against aspiration
- Adjuvant therapy: Radiation (± chemotherapy) for T3/T4 disease, positive margins, nodal metastases, extracapsular spread, PNI, LVI
ADVANTAGES
| Feature | NTL |
|---|
| Voice | Lung-powered, natural-sounding voice - no prosthesis |
| Aspiration protection | Yes - innervated dynamic sphincter |
| Avoids TEP complications | No prosthesis leakage, candidiasis, replacement issues |
| Oncological control | Comparable to total laryngectomy in selected cases |
| Patient compliance | High - no device maintenance |
DISADVANTAGES / COMPLICATIONS
Surgical complications:
- Pharyngocutaneous fistula (higher in post-irradiated patients, ~50% post-RT)
- Wound infection
- Shunt stenosis / failure
Functional:
- Permanent tracheostome - loss of nasal respiration
- Shunt stenosis may impair voice
- Aspiration (if shunt sphincter is compromised)
Oncological:
- Not suitable if adequate remnant cannot be preserved
ONCOLOGICAL OUTCOMES
- Locoregional control rates with NTL are comparable to total laryngectomy in properly selected cases
- Local recurrence rate: < 7% in predominantly T3/T4 series (Scott-Brown's series)
- Median 5-year survival: ~57% for pharyngolaryngectomy cohort (UK national data, n > 1500)
- Scott-Brown's Otorhinolaryngology Head & Neck Surgery
VOICE REHABILITATION AFTER NTL vs. TOTAL LARYNGECTOMY
| Method | NTL | Total Laryngectomy |
|---|
| Natural voice shunt | Yes (primary) | No |
| TEP/voice prosthesis | Not needed | Gold standard (~80% patients) |
| Esophageal speech | Not applicable | Option (~30% master it) |
| Electrolarynx | Not applicable | Option |
After total laryngectomy, tracheoesophageal speech (TEP) using a Singer-Blom prosthesis is the preferred method. NTL was developed partly to avoid the long-term complications of TEP (leakage, candidiasis, granulation tissue, need for prosthesis replacement).
COMPARISON: NTL vs. TOTAL LARYNGECTOMY
| Parameter | Near Total Laryngectomy | Total Laryngectomy |
|---|
| Larynx removed | Almost all (remnant preserved) | Entire larynx |
| Tracheostome | Permanent | Permanent |
| Voice | Natural lung-powered shunt | TEP/esophageal/electrolarynx |
| Nasal respiration | Lost | Lost |
| Organ-sparing | No | No |
| Indication | Selected advanced cancers | All advanced/unsuitable cases |
| Oncological equivalence | Yes (selected cases) | Gold standard |
COMPARISON: NTL vs. SUPRACRICOID PARTIAL LARYNGECTOMY (SCPL)
| Parameter | NTL | SCPL |
|---|
| Tracheostome | Permanent | Temporary (decannulated) |
| Nasal respiration | Lost | Preserved |
| Voice | Shunt-based | Cricohyoidopexy-based (CHEP/CHP) |
| Organ sparing | No | Yes |
| T stage | T3/T4 unsuitable for partial | T2/T3 selected |
SUMMARY
Near total laryngectomy (Pearson's procedure) is an oncologically sound, voice-preserving but non-organ-sparing procedure for advanced laryngeal and hypopharyngeal cancers. It creates a biological, innervated dynamic shunt for lung-powered speech while sacrificing nasal respiration through a permanent tracheostome. Patient selection is key - the contralateral arytenoid and its nerve supply must be tumor-free. In properly selected cases, oncological outcomes equal those of total laryngectomy, with the significant advantage of natural voice production without a prosthesis.
References:
- Cummings Otolaryngology Head and Neck Surgery, 7th ed. - Chapters on Glottic and Laryngeal Surgery
- Scott-Brown's Otorhinolaryngology Head & Neck Surgery - Hypopharyngeal Cancer chapter
- Pearson BW et al., "Near-total laryngectomy", Ann Otol Rhinol Laryngol, 1980